CNS Relative Valuation
CNS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CNS is overvalued; if below, it's undervalued.
Historical Valuation
Cohen & Steers Inc (CNS) is now in the Overvalued zone, suggesting that its current forward PE ratio of 24.70 is considered Overvalued compared with the five-year average of 22.64. The fair price of Cohen & Steers Inc (CNS) is between 55.31 to 71.33 according to relative valuation methord. Compared to the current price of 74.30 USD , Cohen & Steers Inc is Overvalued By 4.16%.
Relative Value
Fair Zone
55.31-71.33
Current Price：74.30
4.16%
Overvalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
7.46
P/B
Median3y
9.28
Median5y
12.03
-0.65
FCF Yield
Median3y
2.75
Median5y
3.23
Competitors Valuation Multiple
The average P/S ratio for CNS's competitors is 4.30, providing a benchmark for relative valuation. Cohen & Steers Inc Corp (CNS) exhibits a P/S ratio of 6.97, which is 62.05% above the industry average. Given its robust revenue growth of 11.36%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Cohen & Steers Inc (CNS) currently overvalued or undervalued?
What is Cohen & Steers Inc (CNS) fair value?
How does CNS's valuation metrics compare to the industry average?
What is the current P/B ratio for Cohen & Steers Inc (CNS) as of Jul 17 2025?
What is the current FCF Yield for Cohen & Steers Inc (CNS) as of Jul 17 2025?
What is the current Forward P/E ratio for Cohen & Steers Inc (CNS) as of Jul 17 2025?